Receive the comprehensive genome analysis you need for your research project. Whole genome sequencing (WGS) provides unprecedented access to genomic information — expediting breakthroughs in human healthcare, oncology, biomarker discovery, agriculture, and metagenomics.

GENEWIZ’s expertise in the latest technologies and bioinformatics enable us to deliver high-quality data and analysis for the genomes of all organisms, including humans, animals, plants, bacteria, and viruses.



Whole Genome Sequencing Services

Short-Read Human WGS

Analyze human genomes with speed and accuracy using the Illumina® NovaSeq™ or HiSeq®. CLIA-compliant whole genome sequencing is available for clinical researchers.

Short-Read Non-Human WGS

Perform de novo assembly and variant detection on the Illumina® MiSeq®, HiSeq®, or NovaSeq™ with optimal throughput and low cost per base. Extraction through data analysis is available.

Long-Read Whole Genome Sequencing

Long-read sequencing on the PacBio® Sequel® delivers up to 60 kb reads with contig N50 > 1 Mb. Generate reference quality assemblies for prokaryotic genomes. Ideal for structural variant calling in eukaryotes.

Long-Range Phasing

Linked-read sequencing, using the 10x Genomics® Chromium™ and Illumina platforms, enables long-range analysis. Phase SNVs, INDELs, and structural variants across >10 Mb haplotype blocks.

Low-Pass Whole Genome Sequencing

Accurately detect genetic variation throughout genomes of a multitude of species. Achieve up to 99% accuracy of variant call detection at a very low sequence coverage (0.1X<10X) using imputation algorithms.



Find the right NGS solution for your project using our interactive guide.


Features & Benefits

  • Building

    Superior Data Quality
    Exceeding manufacturer’s benchmarks
  • Building

    Fast Turnaround
    Starting at 1 week for sequencing
  • Building

    US-Based Processing
    Sequencing and customer support in New Jersey
Dedicated Ph.D.-level support at every step with real-time project updates through our online system
Complete sequencing solutions from extraction to data analysis with many sample types accepted
Automated workflows increase scalability and improve reproducibility​
Single-cell whole genome sequencing with CNV profiling available on the 10x Genomics platform

More reasons to choose GENEWIZ

Case Study | Detection of Previously Unidentified Structural Variants Involved in Glioblastoma Using PacBio® Sequel® Sequencing

This case study looks at how GENEWIZ utilized the PacBio Sequel long-read technology to help a customer improve detection of structural variants within glioblastoma samples.

Webinar | A New Paradigm in DNA Sequencing – Highly Accurate Single-Molecule Long Reads (Hosted by PacBio)

In this PacBio-hosted webinar, Jonas Korlach, PacBio Chief Scientific Officer, and Dave Corney, GENEWIZ Associate Principal Scientist, Next Generation Sequencing, describe the recent release of Sequel System 6.0, which has revolutionized long-read sequencing by providing users the ability to generate highly accurate single-molecule reads.

Tech Note | Multiplexing Microbes on the PacBio Sequel: Feasibility, Benefits, and Recent Developments

This study proves the feasibility of multiplexing and highlights the key advantages of the PacBio Sequel platform as compared to its predecessor, the RSII.

Best Practices | Preparation of High Molecular Weight DNA

High-quality high molecular weight (HMW) genomic DNA (≥50 kb) is critical to achieving long read lengths on platforms such as the 10x Genomics® Chromium™ and the PacBio Sequel. Follow these guidelines to generate the best possible WGS results.

The $100 Genome: Using Low-Pass Whole Genome Sequencing as an Alternative to Genotyping Arrays

In this webinar originally presented at the ASHG 2020 Virtual Meeting, learn how low-pass WGS overcomes the inherent limitations and biases of traditional arrays, offering an inexpensive, high-throughput alternative for detecting genome-wide genetic variation and novel variants.





How To Order

Email | Phone (1-877-GENEWIZ (436-3949), Ext. 1)